Study on Diastolic Dysfunction in Newly Diagnosed Type 2 Diabetes Mellitus and its Correlation with Glycosylated Haemoglobin (HbA1C)

被引:34
|
作者
Chaudhary, Abhay Kumar [1 ]
Aneja, Girish Kumar [2 ]
Shukla, Shubhra [3 ]
Razi, Syed Mohd [4 ]
机构
[1] ESI PGIMER, Dept Internal Med, New Delhi, India
[2] LLRM Med Colllege, Dept Med, Meerut, Uttar Pradesh, India
[3] Stanley Med Coll, Dept Dermatol, Chennai, Tamil Nadu, India
[4] LLRM Med Coll, Dept Endocrinol & Metab, Meerut, Uttar Pradesh, India
关键词
BMI; Diabetic cardiomyopathy; Normotensive;
D O I
10.7860/JCDR/2015/13348.6376
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Left ventricular diastolic dysfunction (LVDD) represents the first stage of diabetic cardiomyopathy preceding changes in systolic function, reinforcing the importance of early examination of ventricular function in individuals with diabetes mellitus (DM). This cross-sectional study was conducted to determine the incidence of asymptomatic LVDD in newly diagnosed normotensive cases of type 2 diabetes subjects, and its relation to glycosylated haemoglobin (HbA1C), age at the time of diagnosis, body mass index (BMI) and serum total cholesterol. Aim and Objective: To study the incidence of left ventricular diastolic dysfunction (LVDD) and its correlation with HbA1C in normotensive, newly diagnosed type 2 diabetic patients. Materials and Methods: This cross-sectional study was done in western U. P. on 100 patients of newly diagnosed (within 1 month) type 2 DM between patients 30 and 60 years of age, visiting the Medicine and Endocrinology outpatient Department of LLRM Medical College, Meerut. Patients with established type 2 diabetes and already taking antidiabetic treatment, cardiac diseases like valvular heart disease, ischemic and hypertensive heart disease, congestive heart failure, cardiomyopathy, renal failure, chronic pulmonary disease, severe anaemia and haemoglobinopathies were excluded from the study. These patients were informed about the study and informed consent was obtained before proceeding with the investigations. Patients selected were evaluated with relevant investigations like fasting and post prandial blood sugar, HbA1C level, lipid profile and 2D echocardiography to assess LVDD. These selected patients were divided in 2 groups; one with left ventricular diastolic dysfunction (LVDD) and second group of subjects without LVDD. Various parameters like HbA1C, age, body mass index and serum cholesterol were evaluated between these 2 groups. Statistical analysis was performed using Student t-test, Chisquare and Fisher Exact-test. Results: Out of 100 patients 65 were males and 35 females. Mean age of the population was 50.08 +/- 6.32 years. Overall incidence of LVDD was 41%. Grade 1 LVDD was most common. Mean HbA1C level of LVDD group was found higher as compared to those without LVDD. Conclusion: LVDD is very common at the time of diagnosis of type 2 DM even in normotensive patients independent of confounding effect of hypertension, ischemia and BMI. HbA1C and age, were found to be strong indicators of LVDD in newly diagnosed cases of Type 2 DM.
引用
收藏
页码:OC20 / OC22
页数:3
相关论文
共 50 条
  • [31] INTERFERENCE OF CARBAMYLATED HEMOGLOBIN IN GLYCOSYLATED HAEMOGLOBIN (HbA1c) ANALYSIS
    Subramaniam, S.
    Shyama, S.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A46 - A47
  • [32] THE IMPACT OF BASELINE HBA1C AND HBA1C TRAJECTORIES ON TIME TO THERAPY ESCALATION IN TYPE 2 DIABETES MELLITUS
    McEwan, P.
    Foos, V
    Larnotte, M.
    VALUE IN HEALTH, 2015, 18 (07) : A698 - A698
  • [33] Evaluation of HbA1c as a Screening for Type 2 Diabetes Mellitus in Korea
    Yang, Taeyoung
    Kim, Ji-Hun
    Yun, Mijung
    Choi, Kui Sung
    Park, Byung Soon
    Kim, Soul
    Ro, Eun Young
    DIABETES, 2015, 64 : A410 - A410
  • [34] Seasonal variation in HbA1c in patients with Type 2 diabetes mellitus
    Carney, TA
    Guy, SP
    Helliwell, CD
    DIABETIC MEDICINE, 2000, 17 (07) : 554 - 555
  • [35] Low HbA1c levels and mortality in type 2 diabetes mellitus
    Shamsa Ali
    Vivian A. Fonseca
    Nature Reviews Endocrinology, 2010, 6 : 359 - 360
  • [36] Beyond HbA1c cardiovascular protection in type 2 diabetes mellitus
    Adamu, U. G.
    Mpanya, D.
    Patel, A.
    Tsabedze, N.
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2023, 28 (01) : 7 - 13
  • [37] POSTMORTEM GLYCOSYLATED HEMOGLOBIN (HBA1C) - EVIDENCE FOR A HISTORY OF DIABETES-MELLITUS
    CHEN, C
    GLAGOV, S
    MAKO, M
    ROCHMAN, H
    RUBENSTEIN, AH
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1983, 13 (05): : 407 - 410
  • [38] Effect of Type-2 Diabetes Mellitus in Retinopathy Patients on MDA, SOD Activity and its Correlation with HbA1c
    Hou, Yali
    Lin, Mei
    Qiu, Xuan
    He, Mingjuan
    Zhang, Yu
    Guo, Feifei
    BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY, 2021, 64
  • [39] Glycated haemoglobin A1c (HbA1c) in the diagnosis of diabetes mellitus: don't forget the performance of the HbA1c assay
    Schindhelm, R. K.
    Lenters-Westra, E.
    Slingerland, R. J.
    DIABETIC MEDICINE, 2010, 27 (10) : 1214 - 1215
  • [40] Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus and its Association with Age, Gender, Duration and Glycosylated Haemoglobin: A Cross-sectional Study
    Shukla, Sawan kumar
    Tilkar, Mahendra
    Kapur, Karan Saran
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (04) : OC27 - OC30